Research discoveries revealing the genetic causes of neurological degeneration could be a key to slowing the progression of devastating diseases.
13 August 2018
An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.
14 August 2017
A $2.3M grant from The Australian Cancer Research Foundation is being awarded to UQ’s Institute for Molecular Bioscience today to establish the new ACRF Cancer Ultrastructure and Function Facility.
15 November 2016
A future where no children suffer deadly brain tumours may be within reach, thanks to the vision of a team of researchers from The University of Queensland and generous funding.
2 November 2016.jpg?itok=mqcCRg-W "Protagonist Therapeutics founder Associate Professor Mark Smythe")
Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
31 October 2016
University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.
22 August 2016
Professor Jenny Martin from the Institute for Molecular Bioscience is a finalist for a Pride of Australia Medal in the Inspiration category.
1 September 2015
University of Queensland research to prevent, treat and diagnose a range of cancers has been boosted by the injection of $1.78 million in Cancer Council Queensland funding.
4 February 2015-1.jpg?itok=QN9FTh6S "UQ’s Institute for Molecular Bioscience Director Brandon Wainwright, left, Minister for Science, Information Technology, Innovation and the Arts Ian Walker, Queensland Premier Campbell Newman and lead researcher Professor Sean Grimmond.")
University of Queensland scientists have succeeded in identifying the major underlying mutations in pancreatic and ovarian cancers, two of Australia’s most ruthless cancers.
8 July 2014Research projects understanding how cells migrate and developing improved treatments for drug-resistant tuberculosis have been recognised as some of the best in the country by the National Health and Medical Research Council (NHMRC).
1 November 2013A team of researchers has pinpointed a handful of genes that could drive the formation of medulloblastoma, the most aggressive and frequent form of brain tumour found in children.
31 October 2013
After years of losing patients to brain tumours — despite having access to the best of modern medicine — a Brisbane neurosurgeon has had enough.
15 October 2013The University of Queensland-based Protagonist Therapeutics, Inc. has announced the completion of a $14 million Series B venture financing initiative.
10 July 2013
Skin cancer research by a University of Queensland team features in a new National Health and Medical Research Council publication launched this month.
24 August 2012Research into using plant seeds to produce otherwise costly drugs has snagged Dr Joshua Mylne the inaugural IMB Fellowship, the Professor John S. Mattick Fellowship.
18 August 2010Medical research worth $40 million will commence at The University of Queensland in 2010, thanks to funding announced by the Federal Government today.
29 October 2009Cancer drugs may soon grow on trees if a University of Queensland researcher has his way.
24 September 2009
University of Queensland (UQ) researchers will use a $5 million grant from the Queensland State Government to unlock the genetic causes of pancreatic and ovarian cancer.
20 May 2009Scientists at The University of Queensland (UQ) will use a record research grant to give new hope to patients with two of Australia's most fatal cancers.
26 March 2009
